Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-02-26 Sale | 2024-02-27 6:13 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 772 | $24.67 | $19,045 | 22,420 (Direct) | View |
2024-02-26 Sale | 2024-02-27 6:10 pm | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 624 | $24.67 | $15,394 | 32,539 (Direct) | View |
2024-02-26 Sale | 2024-02-27 6:07 pm | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 474 | $24.67 | $11,694 | 12,231 (Direct) | View |
2024-02-26 Sale | 2024-02-27 6:02 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 5,577 | $24.67 | $137,585 | 112,836 (Direct) | View |
2024-01-08 Sale | 2024-01-09 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 3,732 | $29.96 | $111,811 | 96,521 (Direct) | View |
2024-01-08 Sale | 2024-01-09 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 731 | $29.96 | $21,901 | 30,949 (Direct) | View |
2024-01-08 Sale | 2024-01-09 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary | 590 | $29.96 | $17,676 | 46,901 (Direct) | View |
2023-12-15 Sale | 2023-12-15 7:37 pm | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer | 2,000 | $28.3 | $56,600 | 11,025 (Direct) | View |
2023-11-20 Sale | 2023-11-21 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 4,960 | $22.64 | $112,294 | 70,045 (Direct) | View |
2023-11-20 Sale | 2023-11-21 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer | 5,108 | $22.64 | $115,645 | 60,138 (Direct) | View |
2023-11-20 Sale | 2023-11-21 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer | 1,985 | $22.64 | $44,940 | 28,887 (Direct) | View |
2023-10-06 Sale | 2023-10-06 10:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary | 16,369 | $21.96 | $359,463 | 106,146 (Direct) | View |
2023-10-06 Sale | 2023-10-06 9:59 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 51,563 | $21.96 | $1,132,323 | 262,463 (Direct) | View |
2023-09-15 Sale | 2023-09-19 6:31 pm | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer | 2,000 | $25.88 | $51,760 | 10,778 (Direct) | View |
2023-08-21 Sale | 2023-08-23 7:31 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer | 10,000 | $29 | $289,970 | 15,682 (Direct) | View |
2023-07-14 Sale | 2023-07-18 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 100,000 | $30.04 | $3,004,350 | 256,695 (Direct) | View |
2023-07-11 Sale | 2023-07-13 8:27 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 71,602 | $25.04 | $1,792,899 | 36,695 (Direct) | View |
2023-06-15 Sale | 2023-06-16 4:38 pm | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer | 2,000 | $24.15 | $48,300 | 9,144 (Direct) | View |
2023-06-12 Sale | 2023-06-14 5:14 pm | ACADIA PHARMACEUTICALS INC | ACAD | Brege Laura Director | 4,500 | $24.87 | $111,906 | 13,502 (Direct) | View |
2023-06-08 Sale | 2023-06-12 8:48 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer | 974 | $25.02 | $24,369 | 24,717 (Direct) | View |
2023-05-22 Purchase | 2023-05-24 5:09 pm | ACADIA PHARMACEUTICALS INC | ACAD | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner | 896,522 | $25.33 | $22,707,098 | 39,523,425 (Indirect Direct) | View |
2023-05-17 Sale | 2023-05-19 6:54 pm | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer | 5,947 | $22.5 | $133,808 | 30,970 (Direct) | View |
2023-05-17 Sale | 2023-05-19 6:48 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer | 15,310 | $22.5 | $344,475 | 71,469 (Direct) | View |
2023-05-17 Sale | 2023-05-19 6:43 pm | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 14,869 | $22.5 | $334,553 | 73,920 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-02-23 Exercise | 2024-02-27 6:13 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 1,353 | $0 | 22,420 (Direct) | View |
2024-02-23 Exercise | 2024-02-27 6:10 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 1,107 | $0 | 32,539 (Direct) | View |
2024-02-23 Exercise | 2024-02-27 6:07 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 840 | $0 | 12,231 (Direct) | View |
2024-02-23 Exercise | 2024-02-27 6:02 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 10,946 | $0 | 112,836 (Direct) | View |
2024-02-06 Option Award | 2024-02-08 5:09 pm | N/A 2034-02-05 | ACADIA PHARMACEUTICALS INC | ACAD | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | 152,478 | $0 | 152,478 (Direct) | View |
2024-01-06 Exercise | 2024-01-09 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 9,528 | $0 | 96,521 (Direct) | View |
2024-01-06 Exercise | 2024-01-09 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 1,287 | $0 | 30,949 (Direct) | View |
2024-01-06 Exercise | 2024-01-09 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary | 1,634 | $0 | 46,901 (Direct) | View |
2023-11-24 Gift | 2023-11-28 5:32 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director | 2,918 | $0 | 15,862 (Direct) | View |
2023-11-17 Exercise | 2023-11-21 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 9,912 | $0 | 70,045 (Direct) | View |
2023-11-17 Exercise | 2023-11-21 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer | 9,912 | $0 | 60,138 (Direct) | View |
2023-11-17 Exercise | 2023-11-21 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer | 3,964 | $0 | 28,887 (Direct) | View |
2023-10-12 Exercise | 2023-10-16 5:30 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Ndu Adora Director | 4,381 | $0 | 8,762 (Direct) | View |
2023-10-05 Exercise | 2023-10-06 10:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary | 36,174 | $0 | 106,146 (Direct) | View |
2023-10-06 Exercise | 2023-10-06 9:59 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 207,998 | $0 | 262,463 (Direct) | View |
2023-07-14 Exercise | 2023-07-18 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 100,000 | $20.77 | 256,695 (Direct) | View |
2023-07-14 Exercise | 2023-07-18 6:00 pm | N/A 2024-07-14 | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 100,000 | $0 | 256,695 (Direct) | View |
2023-06-08 Exercise | 2023-06-12 8:48 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer | 1,893 | $0 | 24,717 (Direct) | View |
2023-06-01 Option Award | 2023-06-05 9:46 pm | N/A 2033-05-31 | ACADIA PHARMACEUTICALS INC | ACAD | SOLAND DANIEL B Director | 17,697 | $0 | 45,699 (Direct) | View |
2021-06-22 Exercise | 2023-06-05 9:46 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | SOLAND DANIEL B Director | 18,002 | $0 | 45,699 (Direct) | View |
2023-06-01 Option Award | 2023-06-05 9:43 pm | N/A 2033-06-01 | ACADIA PHARMACEUTICALS INC | ACAD | Ndu Adora Director | 17,697 | $0 | 17,697 (Direct) | View |
2023-06-01 Option Award | 2023-06-05 9:42 pm | N/A 2033-05-31 | ACADIA PHARMACEUTICALS INC | ACAD | Brege Laura Director | 17,697 | $0 | 35,699 (Direct) | View |
2021-06-22 Exercise | 2023-06-05 9:42 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Brege Laura Director | 18,002 | $0 | 35,699 (Direct) | View |
2023-06-01 Option Award | 2023-06-05 9:39 pm | N/A 2033-05-31 | ACADIA PHARMACEUTICALS INC | ACAD | HARRIGAN EDMUND Director | 17,697 | $0 | 36,699 (Direct) | View |
2021-06-22 Exercise | 2023-06-05 9:39 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | HARRIGAN EDMUND Director | 18,002 | $0 | 36,699 (Direct) | View |
2023-06-01 Option Award | 2023-06-05 9:38 pm | N/A 2033-05-31 | ACADIA PHARMACEUTICALS INC | ACAD | Daly James M Director | 17,697 | $0 | 35,699 (Direct) | View |
2021-06-22 Exercise | 2023-06-05 9:38 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Daly James M Director | 18,002 | $0 | 35,699 (Direct) | View |
2023-06-01 Option Award | 2023-06-05 9:34 pm | N/A 2033-05-31 | ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director | 17,697 | $0 | 36,477 (Direct) | View |
2022-06-07 Exercise | 2023-06-05 9:34 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director | 16,862 | $0 | 36,477 (Direct) | View |
2023-06-01 Option Award | 2023-06-05 5:14 pm | N/A 2033-05-31 | ACADIA PHARMACEUTICALS INC | ACAD | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner | 35,394 | $0 | 39,558,819 (Indirect) | View |
2023-05-23 Exercise | 2023-05-24 5:09 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner | 12,500 | $17.01 | 39,523,425 (Indirect) | View |
2023-05-23 Exercise | 2023-05-24 5:09 pm | N/A 2023-06-07 | ACADIA PHARMACEUTICALS INC | ACAD | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner | 25,000 | $0 | 39,523,425 (Indirect) | View |
2023-05-17 Exercise | 2023-05-19 6:54 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer | 11,894 | $0 | 30,970 (Direct) | View |
2023-05-17 Exercise | 2023-05-19 6:48 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer | 29,738 | $0 | 71,469 (Direct) | View |
2023-05-17 Exercise | 2023-05-19 6:43 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 29,738 | $0 | 73,920 (Direct) | View |
2023-05-01 Option Award | 2023-05-03 9:17 pm | N/A 2033-05-01 | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 117,195 | $0 | 117,195 (Direct) | View |
2023-05-01 Option Award | 2023-05-03 9:16 pm | N/A 2033-05-01 | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 385,067 | $0 | 385,067 (Direct) | View |
2023-05-01 Option Award | 2023-05-03 9:15 pm | N/A 2033-05-01 | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer | 117,195 | $0 | 117,195 (Direct) | View |
2023-05-01 Option Award | 2023-05-03 9:14 pm | N/A 2033-05-01 | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary | 78,129 | $0 | 78,129 (Direct) | View |
2023-05-01 Option Award | 2023-05-03 9:13 pm | N/A 2033-05-01 | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer | 27,515 | $0 | 27,515 (Direct) | View |